
Tim Boreham: Alterity Therapeutics (@AlterityT) is closing in on a pivotal phase III trial for Multiple System Atrophy (MSA), a rare and rapidly progressive disease often misdiagnosed as Parkinson's.
Read more: buff.ly/B9FfhKr
#ASX #Investing #biotechnology $ATH
English






